VIVUS to Present at Three Investor Conferences in February 2013
MOUNTAIN VIEW, Calif., Feb. 8, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy E. Morris, chief financial officer, will present an overview of the company at three investment conferences during the month of February 2013.
The conference presentation schedule is as follows:
Leerink Swann 2013 Global Healthcare Conference February 13, 2013, 12:00 noon EST Waldorf Astoria Hotel New York, NY Citi Equities 2013 Global Healthcare Conference February 27, 2013, 11:05am EST Hilton New York New York, NY RBC Capital Markets Healthcare Conference February 27, 2013, 2:00pm EST New York Palace Hotel New York, NY
A live webcast and 30-day archive of the presentations will be available at http://ir.vivus.com.
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health for U.S., Europe and other world markets. For more information about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2011, and periodic reports filed with the Securities and Exchange Commission.